Agilent Technologies
Search: in
 |
Products & Services
| |
Industries
| |
Customer Center
| |
About Agilent
|
|
Registration
|
+
Corporate Report 2004
 
our products

Cancer diagnosis and therapy

Progress is being made in the fight against cancer – the 10th leading cause of death worldwide in 2003, according to the World Health Organization. Many cancer researchers use the Agilent DNA microarray platform for gene expression profiling to better understand how cancer begins, develops and progresses. Agilent now is developing specialized DNA microarrays for comparative genomic hybridization (CGH), a technique that allows researchers to study chromosomal changes in cancer and informs them about progression of patients in a way never before possible.

Agilent Labs is working with scientists in other research organizations, such as the Translational Genomics Research Institute, to develop commercial CGH solutions. The solutions use Agilent’s ink-jet DNA microarray manufacturing process, in which short strands of DNA called oligonucleotides are synthesized base by base directly on a glass slide.



Privacy Statement  ·  Terms of Use  ·  Webmaster  ·  United States Home  ·  © Agilent 2000-2019